{"issuance_frequency":"","notes_translated":{"fr":"Ce projet vise à élargir le processus d'évaluation prioritaire des présentations de médicaments qui répondent aux besoins du système de santé. Il permettra à la population canadienne d'accéder plus rapidement aux médicaments, y compris ceux pour les maladies rares.\r\n","en":"This project will build new review pathways for those drugs shown to meet health care system needs. The outcome for the people of Canada will be faster access to drugs, including drugs for rare diseases.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"0408076e-f46d-47d0-88ad-9054ea4558fc","metadata_created":"2020-09-17T20:11:00.569554","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-17T20:11:00.569560","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-09-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["évaluation prioritaire","accès plus rapide aux médicaments","besoins du système de santé"],"en":["Priority review","faster access to drugs","health care system needs."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Élargissement du processus d'évaluation prioritaire des présentations de médicaments répondant aux besoins du système de santé","en":"Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"0408076e-f46d-47d0-88ad-9054ea4558fc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"05b3979e-cd2c-48ab-a67b-913409401f57","related_relationship":"","name_translated":{"fr":"Élargissement du processus d'évaluation prioritaire des présentations de médicaments répondant aux besoins du système de santé","en":"Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs","language":["en"],"created":"2020-09-17T20:11:00.669045","url":"https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/expanding-priority-review-pathways-for-drugs-meet-health-care-system-needs.html","last_modified":null,"position":0,"revision_id":"5eabf5e8-9949-4c01-b048-54c8fc31c167","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"0408076e-f46d-47d0-88ad-9054ea4558fc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3b92e293-1d62-4be8-b68f-9d4e73d49c45","related_relationship":"","name_translated":{"fr":"Élargissement du processus d'évaluation prioritaire des présentations de médicaments répondant aux besoins du système de santé","en":"Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs","language":["fr"],"created":"2020-09-17T20:11:00.669051","url":"https://www.canada.ca/fr/sante-canada/organisation/transparence/transparence-ouverture-en-matiere-reglementation/examens-reglementaire-materiel-medical/elargissement-processus-prioritaire-medicaments-repondant-aux-besoins-du-systeme-sante.html","last_modified":null,"position":1,"revision_id":"5eabf5e8-9949-4c01-b048-54c8fc31c167","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2018-02-16 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"0408076e-f46d-47d0-88ad-9054ea4558fc","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This project will build new review pathways for those drugs shown to meet health care system needs. The outcome for the people of Canada will be faster access to drugs, including drugs for rare diseases.\r\n","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs","revision_id":"5eabf5e8-9949-4c01-b048-54c8fc31c167"}